Résumé
Les étiologies cardiovasculaires représentent une source de recrutement importante pour les services des urgences et sont à l’origine d’une prescription croissante d’analyses biologiques. Les maladies cardiovasculaires représentent une des premières causes de mortalité dans les pays industrialisés et l’incidence des syndromes coronariens aigus en France est de 280 pour 100 000 chez les hommes et 60 pour 100 000 chez les femmes.
This is a preview of subscription content, log in via an institution to check access.
References
Ohman EM, Casey C, Bengtson JR et al. Early detection of acute myocardial infarction: additinal diagnostic information from serum concentrations of myoglobin in patients without ST elevation. Br Heart J 1990; 63: 335–8.
Brogan GX, Jr, Friedman S, McCuskey C et al. Evaluation of a new rapid quantitative immunoassay for serum myoglobin versus CKMB for ruling out acute myocardial infarction in the emergency department. Ann Emerg Med 1994; 24: 665–71.
Lefèvre G. Les troponines: aspects biologiques et cliniques. Ann. Biol. Clin. 2000; 58: 39–48.
Mathieu M. Creatine kinase. In: Références en Biologie Clinique G. Siest, J Henny, F Schiele Eds, Collection Option Bio Elsevier 1990; p 247–260.
Apple FS, Quist HE, Doyle PJ et al. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Socirety of Cardiology/American College of cardiology consensus recommendations. Clin Chem 2003; 49: 1331–6.
Yeo KT, Wu AH, Apple FS, Kroll MH et al. Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta 2003; 338: 107–15.
Harrison A, Morrison LK, Krishanaswamy P et al. B-type natriuretic peptide (BNP) predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med 2002; 39: 131–8.
Bertrand ME, Simoons ML, Fox KA et al. Management of acute coronary syndromes: acute corornary syndromes without persistent ST segment elevation; recommandations of the Task Force of the European Society of Cardiology. Eur Heart J 2000; 21: 1406–32.
Panteghini M, Gerhardt W, Apple FS et al. Quality specification for cardiac troponin assays. Clin Chem Lab Med 2001; 39: 175–9.
Panteghini M, Pagani F, Yeo KT et al. Evaluation of the imprecision at low range concentrations of the assays for cardiac troponin determination. Clin Chem 2004; 50: 327–332.
Morrow DA, Cannon CP, Rifai N, et al. Ability of minor elevations of troponin I and T to identify patients with unstable angina and non-St elevation myocardial infarction who benefit from an early invasive strategy: Results from a prospective randomised trial. JAMA 2001; 286: 2405–12.
Maisel AM, Krishnaswamy P, Nowak R et al. Beside B-natriuretic peptide in the emergency diagnosis of heart failure: primary results from the Breathing Not Properly (BNP) Multinational Study. N Engl J Med 2002; 347: 161–7.
Ridker PM, Hennekens CH, Buring JE et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disase in women. N Engl J Med 2000; 342: 836–843.
Wu AHB, Crosby P, Fagan G. et al. Ischemia modified albumin, free fatty acids, whole blood choline, B type natriuretic peptide, Glycogen phosphorylase BB and cardiac troponin. In Cardiac Marker, 2nd editions Humana Press 2003; p 259–277.
Christenson RH, Duh SH, Sandai WR et al. Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 2001; 47: 464–70.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lefèvre, G. Marqueurs biologiques de souffrance cardiaque. Bio trib. mag. 10, 30–32 (2004). https://doi.org/10.1007/BF03010201
Issue Date:
DOI: https://doi.org/10.1007/BF03010201